Keytruda for Hodgkin's Lymphoma User Reviews
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Hodgkin's Lymphoma
Care guides
Symptoms and treatments
More about Keytruda (pembrolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (211)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"Recurrent Hodgkin lymphoma and Keytruda put me in remission immediately, first infusion. It is a miracle drug for many! However, side effects after 7 months of treatment were becoming unbearable and ceased. Skin and lung issues from first month. Been 3 months since stopping infusions and seem to be improving!"